- 全部删除
您的购物车当前为空
IDH2R140Q-IN-2 是一种具有口服活性和高效性的 IDH2R140Q 抑制剂,IC50为29 nM。IDH2R140Q-IN-2 具有潜在的抗肿瘤活性,能减少携带IDH2R140Q突变的TF-1细胞系中D2HG的生成(IC50为10 nM),抑制肿瘤组织中D2HG的水平。IDH2R140Q-IN-2适用于研究急性髓系白血病(AML)。


为众多的药物研发团队赋能,
让新药发现更简单!
IDH2R140Q-IN-2 是一种具有口服活性和高效性的 IDH2R140Q 抑制剂,IC50为29 nM。IDH2R140Q-IN-2 具有潜在的抗肿瘤活性,能减少携带IDH2R140Q突变的TF-1细胞系中D2HG的生成(IC50为10 nM),抑制肿瘤组织中D2HG的水平。IDH2R140Q-IN-2适用于研究急性髓系白血病(AML)。
| 规格 | 价格 | 库存 | 数量 |
|---|---|---|---|
| 1 mg | ¥ 2,960 | In stock | |
| 5 mg | ¥ 7,000 | In stock | |
| 10 mg | ¥ 8,590 | In stock | |
| 25 mg | ¥ 11,200 | In stock | |
| 50 mg | ¥ 13,800 | In stock | |
| 100 mg | ¥ 17,500 | In stock |
IDH2R140Q-IN-2 相关产品
| 产品描述 | IDH2R140Q-IN-2 is an orally active and potent IDH2R140Q inhibitor with an IC50 of 29 nM.IDH2R140Q-IN-2 possesses potential antitumour activity, reducing D2HG production in TF-1 cell lines carrying the IDH2R140Q mutation (IC50 of 10 nM) and inhibiting tumour tissue D2HG levels.IDH2R140Q-IN-2 is suitable for the study of acute myeloid leukaemia (AML). |
| 分子量 | 484.4 |
| 分子式 | C21H18F6N6O |
| CAS No. | 2749568-16-7 |
| Smiles | FC(F)(F)C=1C=CC=C(C1)NC=2N=C(N=C(N2)N3CCC(O)C3)NC4=CC=CC(=C4)C(F)(F)F |
| 存储 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
评论内容